Back to Search
Start Over
Application of estimand framework in ICH E9 (R1) to vaccine trials.
- Source :
- Journal of Biopharmaceutical Statistics; 2023, Vol. 33 Issue 4, p502-513, 12p
- Publication Year :
- 2023
-
Abstract
- Over the past decades, the primary interest in vaccine efficacy or immunogenicity evaluation mostly focuses on the biological effect of immunization in complying with the vaccination schedule in a targeted population. The safety questions, which are essential for vaccines as they are generally given to large healthy populations, need to be clearly defined to reflect the risk assessment of interest. ICH E9 (R1) provides a structured framework to clarify the clinical questions and formulate the treatment effect as an estimand. This paper applies the estimand framework to vaccine clinical trials on common clinical questions regarding efficacy, immunogenicity, and safety. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 10543406
- Volume :
- 33
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Journal of Biopharmaceutical Statistics
- Publication Type :
- Academic Journal
- Accession number :
- 164556163
- Full Text :
- https://doi.org/10.1080/10543406.2023.2197040